Rapt Therapeutics Inc (RAPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -69,204 | -51,275 | -32,624 | -16,514 | -52,892 |
| Depreciation Amortization | 2,266 | 1,605 | 966 | 498 | 1,620 |
| Other Working Capital | -4,298 | 1,178 | -1,851 | -619 | 2,344 |
| Other Operating Activity | 10,210 | 8,147 | 5,683 | 2,725 | 8,437 |
| Operating Cash Flow | $-61,026 | $-40,345 | $-27,826 | $-13,910 | $-40,491 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -164,977 | -148,050 | -118,705 | -15,734 | -139,334 |
| PPE Investments | -755 | -361 | -291 | -227 | -398 |
| Purchase Of Investment | 84,385 | 82,956 | 67,715 | 28,372 | 52,297 |
| Investing Cash Flow | $-81,347 | $-65,455 | $-51,281 | $12,411 | $-87,435 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 141,482 | 140,881 | 140,409 | 1,301 | 75,461 |
| Financing Cash Flow | $141,482 | $140,881 | $140,409 | $1,301 | $75,461 |
| Beginning Cash Position | 24,918 | 24,918 | 24,918 | 24,918 | 77,383 |
| End Cash Position | 24,027 | 59,999 | 86,220 | 24,720 | 24,918 |
| Net Cash Flow | $-891 | $35,081 | $61,302 | $-198 | $-52,465 |
| Free Cash Flow | |||||
| Operating Cash Flow | -61,026 | -40,345 | -27,826 | -13,910 | -40,491 |
| Capital Expenditure | -755 | -361 | -291 | -227 | -398 |
| Free Cash Flow | -61,781 | -40,706 | -28,117 | -14,137 | -40,889 |